Works matching Mayo Clinic Cancer Center


Results: 901
    1
    5

    Long-term follow-up of chemoimmunotherapy with rituximab, oxaliplatin, cytosine arabinoside, dexamethasone (ROAD) in patients with relapsed CD20+ B-cell non-Hodgkin lymphoma: Results of a study of the Mayo Clinic Cancer Center Research Consortium (MCCRC) MC0485 now known as academic and community cancer research united (ACCRU)

    Published in:
    American Journal of Hematology, 2017, v. 92, n. 10, p. 1004, doi. 10.1002/ajh.24824
    By:
    • Witzig, Thomas E.;
    • Johnston, Patrick B.;
    • LaPlant, Betsy R.;
    • Kurtin, Paul J.;
    • Pederson, Levi D.;
    • Moore Jr, Dennis F.;
    • Nabbout, Nassim H.;
    • Nikcevich, Daniel A.;
    • Rowland, Kendrith M.;
    • Grothey, Axel
    Publication type:
    Article
    6
    7
    8
    9
    10
    11
    12
    13
    14

    Real world outcomes with elotuzumab-based therapies for patients with relapsed refractory multiple myeloma: a Mayo Clinic experience.

    Published in:
    Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01310-z
    By:
    • Parrondo, Ricardo D.;
    • Das, Saurav;
    • Sledge, Hanna;
    • Bergsagel, Leif;
    • Fonseca, Rafael;
    • Leung, Nelson;
    • Kapoor, Prashant;
    • Gertz, Morie;
    • Buadi, Francis;
    • Dispenzieri, Angela;
    • Elliott, Jamie;
    • Fernandez, Andre;
    • Flott, Caitlin;
    • Chanan-Khan, Asher A.;
    • Roy, Vivek;
    • Ailawadhi, Sikander
    Publication type:
    Article
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34

    Retroperitoneal involvement with light chain amyloidosis- case series and literature review.

    Published in:
    Leukemia & Lymphoma, 2021, v. 62, n. 2, p. 316, doi. 10.1080/10428194.2020.1832670
    By:
    • Vaxman, Iuliana;
    • Visram, Alissa;
    • Pasvolsky, Oren;
    • Kumar, Shaji;
    • Dispenzieri, Angela;
    • Buadi, Francis;
    • Dingli, David;
    • Lacy, Martha;
    • Hayman, Suzanne;
    • Kyle, Robert;
    • Kapoor, Prashant;
    • Leung, Nelson;
    • Gonsalves, Wilson;
    • Kourelis, Taxiarchis;
    • Warsame, Rahma;
    • Gertz, Morie
    Publication type:
    Article
    35

    Combined prognostic impact of initial clinical stage and residual cancer burden after neoadjuvant systemic therapy in triple-negative and HER2-positive breast cancer: an analysis of the I-SPY2 randomized clinical trial.

    Published in:
    Breast Cancer Research, 2025, v. 27, n. 1, p. 1, doi. 10.1186/s13058-025-02070-1
    By:
    • Leon-Ferre, Roberto A.;
    • Dimitroff, K.;
    • Yau, C.;
    • Giridhar, K. V.;
    • Mukhtar, R.;
    • Hirst, G.;
    • Hylton, N.;
    • Perlmutter, J.;
    • DeMichele, A;
    • Yee, D;
    • van 't Veer, L;
    • Rugo, H;
    • Symmans, W. F.;
    • Goetz, M. P.;
    • Esserman, L.;
    • Boughey, J. C.
    Publication type:
    Article
    36

    Modifications of the mouse bone marrow microenvironment favor angiogenesis and correlate with disease progression from asymptomatic to symptomatic multiple myeloma.

    Published in:
    OncoImmunology, 2015, v. 4, n. 6, p. 0, doi. 10.1080/2162402X.2015.1008850
    By:
    • Calcinotto, Arianna;
    • Ponzoni, Maurilio;
    • Ria, Roberto;
    • Grioni, Matteo;
    • Cattaneo, Elena;
    • Villa, Isabella;
    • Bertilaccio, Maria Teresa Sabrina;
    • Chesi, Marta;
    • Rubinacci, Alessandro;
    • Tonon, Giovanni;
    • Bergsagel, P Leif;
    • Vacca, Angelo;
    • Bellone, Matteo
    Publication type:
    Article
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47

    Laryngeal chondrosarcomas: The Mayo Clinic experience.

    Published in:
    Journal of Surgical Oncology, 1997, v. 65, n. 4, p. 269, doi. 10.1002/(SICI)1096-9098(199708)65:4<269::AID-JSO8>3.0.CO;2-3
    By:
    • Kozelsky, Timothy F.;
    • Bonner, James A.;
    • Foote, Robert L.;
    • Olsen, Kerry D.;
    • Kasperbauer, Jan L.;
    • McCaffrey, Thomas V.;
    • Lewis, Jean E.;
    • Grill, Joseph P.
    Publication type:
    Article
    48
    49
    50